The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

The auto industry is flashing warning lights on the state of the U.S. economy. Automakers' profits are getting squeezed by tariffs. A subprime auto lender recently collapsed, and some car retailers ...

Find the best ChatGPT alternatives in 2025. Compare Perplexity AI, Claude, Gemini, Abacus.ai, and Copilot for research, ...

Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

From the earliest year of school, children begin learning how to express ideas in different ways. Lines across a page, a ...

The three-lap event, one of eight that day, was won by FC Pycroft in an unusual-looking Jaguar SS100, seeing off a small ...

Research shows us that grieving the death of our companion animals can be just as painful, if not more than, grieving the loss of a family member or friend. There are helpful steps to take immediately ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

The Post welcomes letters up to 250 words on topics of general interest. Letters must include full name, home address, day and evening phone numbers, and may be edited for length, grammar and accuracy ...